BackMedicenna Therapeutics Overview

Medicenna Therapeutics Receivables

Medicenna Therapeutics's receivables is $310K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$306000.00
105.37% YoYΔ $157000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Medicenna Therapeutics Receivables History

Loading

Medicenna Therapeutics vs. peers: Receivables Comparison

Loading

Medicenna Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Medicenna Therapeutics (MDNA) FAQ

As of the most recent data (September 2023), MDNA shows a receivables of $310K. That compares with $150K in the prior-year period — up 105.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MDNA's receivables is now $310K (was $150K) — a 105.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Medicenna Therapeutics is outperforming or lagging.

Tracking MDNA's receivables over time shows whether Medicenna Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $310K That compares with $150K in the prior-year period — up 105.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Medicenna Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $310K) with ownership activity and broader fundamentals.

Medicenna Therapeutics's receivables is $310K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.